Aging is a multifactorial process involving neurodegenerative changes in cell morphology and biochemistry. Aging in females and males is considered as the end of natural protection against age related diseases like osteoporosis, coronary heart disease, diabetes, Alzheimer's disease and Parkinson's disease. These changes increase during menopausal condition in females when the level of estradiol is decreased.
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The objective of this study was to observe the changes in activities of mitochondrial enzymes (monoamine oxidase (MAO), Na + K + ATPase and Ca + ATPase), DNA degradation, and glucose transporter 4 (GLUT4) expression in brains of female rats of 3 months (young), 12 months (adult) and 24 months (old) age groups, and to see whether these changes are restored to normal levels after exogenous administration of estradiol (0.1 g/gm body weight for one month).
The results obtained in the present work revealed that normal aging was associated with significant decrease in the activity of Na + K + ATPase, Ca + ATPase and GLUT4 levels in the brains of aging female rats, and an increase in DNA degradation and MAO activity. The present study showed that estradiol treatment significantly decreased DNA degradation, and MAO activity in brain of aging rats, and a reversal of Na + K + ATPase, Ca + ATPase and GLUT4 levels was achieved.
It can therefore be concluded that estradiol's beneficial effects seemed to arise from its antilipofuscin, antioxidant, antilipidperoxidative effects, implying an overall anti-aging action. The results of this study will be useful for pharmacological modification of the aging process and applying new strategies for control of age related disorders.
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Objectives: Alzheimer's disease (AD) is the most common form of dementia in the elderly. AD is characterized by the presence of amyloid plaques which are formed from deposits of ␤-amyloid protein (Ab). These changes increase during menopausal condition in females when the level of estradiol is decreased. The aim of the present study was to determine the effect of neuropeptide, neurokinin B (NKB) and amyloid beta fragment A␤ (25-35) on 17␤ estradiol (E2) treated aging female rat brain of 3 months (young), 12 months (adult) and 24 months (old) age groups.
Methods: The aged rats (12 and 24 months old) (n = 8 for each group) were given subcutaneous injection of 17␤-estradiol (0.1 g/g body weight) daily for one month. After 30 days of hormone treatment, experimental animals of all the groups were sacrificed and brains were isolated for further study. Aging brain function were assayed by measuring the activities of antioxidant enzymes, monoamine oxidase (MAO), membrane bound ATPases, intracellular calcium levels and lipid peroxidation in presence of neuropeptides.
Results: The results obtained in the present work revealed that increased activities of antioxidant enzymes, membrane bound ATPases and decrease in level of calcium levels, monoamine oxidase activity and lipid peroxidation in presence of NKB and combined NKB and A␤ in vivo estradiol (E2) treated ageing rat brain. NKB treatment reversed the beneficial in preventing some of the age related changes in the brain. An in vitro incubation of E2 treated synaptosomes with A␤ showed toxic effects on all the parameters, while NKB showed stimulating effects and the combined NKB and A␤ showed a partial effects as compared to A␤ (25-35) and NKB alone.
Conclusions: Present study elucidates an antioxidant, neuromodulatory and neuroprotective role of tachykinin peptide NKB against the beta amyloid induced toxicity in E2 treated female rats. NKB treatment reversed the beneficial in preventing some of the age related changes in the brain.
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